Janux Therapeutics, Inc.
JANX
Revenue
0.00
0.000.00%
-Assets
1.06B
▲366.50M▲52.73%
3 Months ChangeLiabilities
38.74M
▼-180.00k▼-0.4625%
3 Months ChangeFree Cash Flow
-15.03M
▼-838.00k▼-5.90%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-07
Form 10-Q
ID: 0000950170-24-092857
2024-08-07
Form 8-K
ID: 0000950170-24-092830
2024-07-22
Form 8-K
ID: 0000950170-24-085321
2024-06-28
Form 8-K
ID: 0000950170-24-079059
2024-05-08
Form 10-Q
ID: 0000950170-24-054966
2024-05-08
Form 8-K
ID: 0000950170-24-054950
2024-03-08
Form 8-K
ID: 0000950170-24-028647
2024-02-29
Form 8-K
ID: 0000950170-24-023257
2024-02-28
Form 8-K
ID: 0000950170-24-022266
2024-02-27
Form 8-K
ID: 0000950170-24-021425